Cardiol Therapeutics (CRDL) Competitors C$1.76 +0.02 (+1.15%) As of 07/16/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock CRDL vs. NOT, PYR, TLRY, NVO, DNA, VBV, CUS, AIM, FRX, and ITHShould you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Tilray Brands (TLRY), Novo Resources Corp. (NVO.V) (NVO), Dalradian Resources (DNA), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), Fennec Pharmaceuticals (FRX), and International Tower Hill Mines (ITH). These companies are all part of the "pharmaceutical products" industry. Cardiol Therapeutics vs. Its Competitors Noront Resources PyroGenesis Canada Inc. (PYR.V) Tilray Brands Novo Resources Corp. (NVO.V) Dalradian Resources VBI Vaccines Chemtrade Electrochem Inc, Aimia Fennec Pharmaceuticals International Tower Hill Mines Cardiol Therapeutics (TSE:CRDL) and Noront Resources (CVE:NOT) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk. Does the media favor CRDL or NOT? In the previous week, Cardiol Therapeutics' average media sentiment score of 0.00 equaled Noront Resources'average media sentiment score. Company Overall Sentiment Cardiol Therapeutics Neutral Noront Resources Neutral Do institutionals and insiders have more ownership in CRDL or NOT? 11.4% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has stronger earnings & valuation, CRDL or NOT? Noront Resources is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardiol TherapeuticsN/AN/A-C$42.93M-C$0.51-3.46Noront ResourcesN/AN/AN/A-C$0.15-7.20 Is CRDL or NOT more profitable? Noront Resources' return on equity of 0.00% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cardiol TherapeuticsN/A -195.07% -54.15% Noront Resources N/A N/A N/A SummaryCardiol Therapeutics and Noront Resources tied by winning 3 of the 6 factors compared between the two stocks. Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRDL vs. The Competition Export to ExcelMetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$146.04MC$2.16BC$5.51BC$6.23BDividend YieldN/A2.92%4.25%6.72%P/E Ratio-3.464.2328.1554.79Price / SalesN/A583.95439.011,148.37Price / Cash0.9810.3535.5383.29Price / Book11.7811.478.235.00Net Income-C$42.93MC$21.15BC$3.23BC$301.20M7 Day Performance-5.38%-0.34%-0.56%0.13%1 Month Performance-5.88%3.75%6.67%3.77%1 Year Performance-39.31%2.19%27.00%24.82% Cardiol Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRDLCardiol TherapeuticsN/AC$1.76+1.1%N/A-41.5%C$146.04MN/A-3.4620NOTNoront ResourcesN/AC$1.10-0.5%N/A+0.0%C$612.18MN/A-7.20101,700PYRPyroGenesis Canada Inc. (PYR.V)N/AC$3.85+11.0%N/A+0.0%C$606.96MC$6.01M-154.0090Gap UpTLRYTilray BrandsN/AC$0.89+12.7%N/A-69.1%C$573.49MC$610.34M-2.152,650NVONovo Resources Corp. (NVO.V)N/AC$2.38-0.4%N/A+0.0%C$548.24MN/A-21.2554,400DNADalradian ResourcesN/AN/AN/AN/AC$519.02MN/A-56.15640VBVVBI VaccinesN/AN/AN/AN/AC$308.86MC$3.36M-4.9722CUSChemtrade Electrochem Inc,N/AN/AN/AN/AC$306.50MN/A0.0060AIMAimia2.3934 of 5 starsC$3.03+1.0%C$4.00+32.0%+10.4%C$291.42MC$464.71M-3.7320News CoverageFRXFennec PharmaceuticalsN/AC$11.89+2.3%N/A+27.5%C$229.30MC$34.86M-201.4110News CoverageGap UpITHInternational Tower Hill MinesN/AC$1.29+0.8%N/A+105.9%C$181.11MN/A-53.90220Gap Down Related Companies and Tools Related Companies Noront Resources Alternatives PyroGenesis Canada Inc. (PYR.V) Alternatives Tilray Brands Alternatives Novo Resources Corp. (NVO.V) Alternatives Dalradian Resources Alternatives VBI Vaccines Alternatives Chemtrade Electrochem Inc, Alternatives Aimia Alternatives Fennec Pharmaceuticals Alternatives International Tower Hill Mines Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CRDL) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRDL Stock Alerts